All News

Top news of the day from across the health care landscape.

Shared decision making is a tool used by health care professionals to educate more thoroughly, and communicate with their patients.

Top news of the week from Specialty Pharmacy Times.

Tazemetostat blocks any activity of the EZH2 methyltransferase, which may help keep the cancer cells from further growth.

Do you know the first pharmacy school established in North America?

Pharmacies are using technology not only to offer safe filling, but generate greater engagement with their customer base.

PTSD can have debilitating effects, including flashbacks, nightmares, and extreme anxiety.

Pfizer will become the first to launch 3 oncology monoclonal antibody biosimilar treatments to the US market.

The study was the first to examine proton pump inhibitors use in breast cancer survivors.

Top news of the day from across the health care landscape.

Opioid agonist therapy (OAT) must be widely disseminated and increased in Ukraine in order to optimize HIV prevention and treatment goals, according to a recent study published in The Lancet.

Pharmacists should advise patients to get vaccinated at least 1 month before going abroad.

A proposed FDA guidance could significantly impact veterinary practices and their ability to compound medicines for animal patients, according to a national survey.1

A study published in the American Journal of Pharmaceutical Education conducted focus groups of pharmacy preceptors to discuss desired business-related skills.

Biosimilars, which at the most simplistic level can be thought of as a type of generic option for a biologic, offer an opportunity to help reduce total biologic drug spend.

Valoctocogene roxaparvovec (Valrox, BioMarin Pharmaceutical Inc) would be the first gene therapy in the United States for the most common form of hemophilia if approved by the FDA.1

The shift from fee-for-service to a value-based care payment model represents the growing understanding of the value of health care providers in improving overall patient outcomes.

The release of generic versions of brand name drugs for patients with multiple sclerosis had little overall effect on the price increase.

Top news of the day from across the health care landscape.

During a health care conference on Thursday, Republican Federal Trade Commissioner Christine Wilson expressed support for allowing Medicare to negotiate drug prices.1

Teprotumumab-trbw is the first drug to be approved for the treatment of thyroid eye disease.

A case of the virus that reportedly originated in Wuhan City, China has been confirmed in Washington State.

Top news of the day from across the health care landscape.

Antiretroviral therapy may not be entirely effective in restoring the immune protection resulting from viral infections or childhood vaccines received prior to becoming HIV-positive.

The report projects changes in upcoming health care markets, including kidney care, digital health, drug cost transparency, the loneliness epidemic, and the self-care market.

According to a survey commissioned by the American Academy of Family Physicians, certain groups, including millennials and African Americans, are more susceptible to anti-vaccination rhetoric and beliefs, with 51% of Americans reporting they have not received a flu shot this season. In addition, nearly one-third of adults who completed the survey do not plan on getting a flu shot.

Since 2006, the CDC has tracked increases in cases and outbreaks about every 5 years.

Girish Dighe, PharmD, MS, explains the importance of change management within a closed-loop system.